Summary
Serum immunoglobulin concentration and skin reactivity to at least three recall antigens were determined in 210 patients with chronic myeloid leukemia (CML). Immunoglobulin concentration was normal in the great majority of the patients. Skin tests were negative in 50 of 210 cases (24%). No relationship could be demonstrated between skin reactivity, age, time since diagnosis, WBC, lymphocyte count, and splenectomy. Prior antileukemic therapy was a major factor in determining the response to skin tests.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aisenberg, A. C.: Manifestations of immunologic unresponsiveness in Hodgkin's disease. Cancer Res. 26, 1152 (1966).
Chase, M. W.: Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis. Cancer 26, 1097 (1966).
Currie, G. A.: Cancer and immune response. In: Current topics in immunology series, Vol. 2. London: Edward Arnold 1974.
Gangal, S. G., Gothoskar, B. P., Joshi, C. S., Advani, S. H.: Demonstration of cellular immunity in chronic myeloid leukemia using leukocyte migration inhibition assay. Br. J. Cancer 33, 267 (1976).
Gothoskar, B. P., D'Silva, H., Gharpure, H., Advani, S. H.: Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reaction. Eur. J. Cancer 12, 815 (1976).
Gunz, F. W., Vincent, P. C.: Towards a cure of acute granulocytic leukemia? Leuk. Res. 1, 51 (1977).
Hellström, I., Hellström, K. E., Pierce, G. E., Yang, J. P. S.: Cellular and humoral immunity to different types of human neoplasms. Nature 220, 1352 (1968).
Hester, J. P., McCredie, K. B., Freireich, E. J.: Immunological evaluation in patients with chronic myelogenous leukemia. Cancer Res. (AACR Abstr.) 15, 180 (1974).
Italian Cooperative Study Group on Chronic Myeloid Leukemia: A clinical trial of early splenectomy, hydroxyurea, and cyclic arabinosyl cytosine, vincristine and prednisone in chronic myeloid leukemia. Ser. Haematol. 8 (4), 121 (1975).
Mohanakumar, T., Miller, D. S., Anderson, J., Metzgar, R. S.: Immunological characterization of normal and leukemia-associated antigens of acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res. 38, 716 (1978).
Piessens, W. F., Moloney, W. C.: Immunological aspects of acute leukemia in man. Eur. J. Cancer 12, 511 (1976).
Powles, R. L.: Tumor-associated antigens in acute leukaemia. In: Advances in acute leukaemias. Cleton, F. J., Crowther, D., Malpas, J. S. (eds.), p. 115. Amsterdam: North-Holland 1974.
Ramachandar, K., Baker, M. A., Taub, R. N.: Antibody responses to leukemia-associated antigens during immunotherapy of chronic myelocytic leukemia. Blood 46, 845 (1975).
Sokal, J. E.: Immunotherapy for chronic granulocytic leukemia. Clin. Haematol. 6, 129 (1977).
Sokal, J. E., Aungst, C. W., Grace, J. J.: Immunotherapy in well-controlled chronic myelocytic leukemia. N.Y. State J. Med. 73, 1180 (1973).
Sokal, J. E., Carpentier, N., Nizet, C.: Progress report on immunotherapy of chronic myeloid leukemia. Boll. Ist. Sieroter. Milan. 57, 294 (1978).
Whitson, M. W., Lozzio, C. B., Wust, C. J., Brawn, A.: Specificity of rabbit antiserum for human chronic myelocytic leukemia cells. Cancer Res. (AACR Abstr.) 15, 142 (1974).
Author information
Authors and Affiliations
Consortia
Additional information
S. Tura (Chairman) and M. Baccarani (Secretary), Cattedra di Ematologia dell'Università e Servizio di Ematologia dell'Ospedale S. Orsola, Bologna; G. de Sandre, G. Perona, G. Cetto, G. Pizzolo, Istituto di Patologia Medica e Cattedra di Ematologia dell'Università, Verona; P. Rambotti, B. Falini, Clinica Medica dell'Università, Perugia; T. Chisesi, G. Capnist, Divisione di Ematologia, Ospedale Civile, Vicenza; A. Cajozzo, P. Citarella, Cattedra di Ematologia dell'Università, Palermo; G. Broccia, Sezione di Ematologia, Ospedale Armando Businco, Cagliari; V. Liso, G. Troccoli, Clinica Medica II dell'Università, Bari; L. Bruzzese, G. Nappi, A. Abbadessa, Clinica Medica (I Facoltà) dell'Università, Napoli; A. Porcellini, C. Delfini, Divisione di Ematologia, Ospedali Riuniti, Pesaro; E. Cacciola, R. Giustolisi, R. Musso, V. Raimondi, Cattedra di Ematologia dell'Università, Catania; G. Torlontano, L. Geraci, Cattedra di Ematologia dell'Università, Chieti, e Divisione di Ematologia, Ospedale Civile, Pescara; F. Mandelli, G. Mariani, B. Monarca, N. Petti, Cattedra di Ematologia dell'Università, Roma; R. di Guglielmo, A. Miliani, Clinica Medica dell'Università, Firenze; C. Bernasconi, M. Lazzarino, G. Castelli, Divisione di Ematologia, Ospedale S. Matteo, Pavia; A. Alberti, S. Magro, Servizio di Ematologia, Ospedale Generale Regionale, Catanzaro; A. Neri, P. Iacopino, Divisione di Ematologia, Ospedali Riuniti, Reggio Calabria; R. Delsignore, M. C. Baroni, Istituto di Patologia Medica dell'Universita, Parma; E. Bajetta, S. Monfardini, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano; S. Tognella, Istituto Scientifico di Medicina Interna, Cattedra di Clinica Medica 2R, Università, Genova.
Rights and permissions
About this article
Cite this article
Gobbi, M., Baccarani, M., Ruggero, D. et al. Delayed hypersensitivity and Ig level in 210 patients with chronic myeloid leukemia. Cancer Immunol Immunother 6, 59–62 (1979). https://doi.org/10.1007/BF00206017
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206017